Engineered microbiome therapy has shown improvement in gut colonization in clinical trials. The therapy, which involves genetically modified bacteria, is being explored for various potential applications, including treating metabolic, cardiovascular, and cerebrovascular diseases, as well as blood cancer and obesity. The use of engineered microbiome therapy is part of a broader area of research into the gut microbiome and its potential to be targeted for therapeutic purposes.